News|Articles|January 1, 2003
- Pharmaceutical Technology-01-01-2003
- Volume 27
- Issue 1
Outsourcing Outlook
Author(s)Jim Miller
Developments in 2002 such as acquisitions, excess manufacturing capacity, and less funding for biotechnology will continue to affect the industry long into the new year.
Advertisement
Articles in this issue
over 23 years ago
Pharmaceutical Pricing and Innovation Key Issues for 2003over 23 years ago
Procedures: Improving Their Qualityover 23 years ago
Drug-Carrier Screening on a Chipover 23 years ago
Pack EXPO International 2002 Proves Worth the Tripover 23 years ago
Analysis of the Indian Pharmaceutical IndustryAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Roche Gets Priority Review for Enspryng; Announces Sequencing Platform
2
FDA Grants First-in-Class Approval for Treg Cell Therapy in Blood Cancer Transplant Patients
3
Manufacturing Deficiencies Behind FDA's Oxylanthanum Carbonate Rejection
4
Regulatory Developments Impacting Biologics
5